Anakinra in mutation-negative NOMID/CINCA syndrome: comment on the articles by Hawkins et al and Hoffman and Patel

Arthritis Rheum. 2004 Nov;50(11):3738-9; author reply 3739-40. doi: 10.1002/art.20497.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Arthritis / drug therapy*
  • Arthritis / genetics
  • Carrier Proteins / genetics*
  • Dermatitis / drug therapy*
  • Dermatitis / genetics
  • Female
  • Humans
  • Infant, Newborn
  • Interleukin 1 Receptor Antagonist Protein
  • Male
  • Mutation
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Neuritis / drug therapy*
  • Neuritis / genetics
  • Sialoglycoproteins / therapeutic use*
  • Syndrome

Substances

  • Antirheumatic Agents
  • Carrier Proteins
  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • NLRP3 protein, human
  • Sialoglycoproteins